WallStreetZenWallStreetZen

NASDAQ: BDTX
Black Diamond Therapeutics Inc Stock Ownership - Who owns Black Diamond Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Black Diamond Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Prakash RamanDirector2025-06-205,526$2.33
$12.88kBuy
Ali BehbahaniDirector2025-06-206,170$2.33
$14.38kBuy
Ali BehbahaniDirector2025-03-217,646$1.88
$14.37kBuy
Prakash RamanDirector2025-03-216,848$1.88
$12.87kBuy
Growth N. V. Biotech10% Owner2025-03-19400,000$2.09
$837.20kSell
Growth N. V. Biotech10% Owner2025-03-19584,292$1.95
$1.14MSell
Growth N. V. Biotech10% Owner2025-03-19500,000$2.12
$1.06MSell
Growth N. V. Biotech10% Owner2025-03-192,000,000$2.00
$4.00MSell
Growth N. V. Biotech10% Owner2025-03-191,000,000$2.07
$2.07MSell
Growth N. V. Biotech10% Owner2025-03-19300,000$1.94
$582.90kSell

1 of 2

BDTX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when BDTX insiders and whales buy or sell their stock.

BDTX Shareholders

What type of owners hold Black Diamond Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
T Rowe Price Investment Management Inc18.29%10,399,241$29.33MInstitution
Ali Behbahani15.78%8,974,664$25.31MInsider
Vestal Point Capital LP9.85%5,600,000$15.79MInstitution
Versant Venture Capital VI LP8.00%4,548,481$12.83MInsider
Nea Management Company LLC7.82%4,448,757$12.55MInstitution
Blackrock Inc6.11%3,472,756$9.79MInstitution
Bellevue Group Ag4.81%2,733,547$7.71MInstitution
Growth N. V. Biotech4.81%2,733,547$7.71MInsider
Vanguard Group Inc4.14%2,356,833$6.65MInstitution
Tang Capital Management LLC3.64%2,070,209$5.84MInstitution

1 of 3

BDTX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
BDTX66.90%33.10%Net SellingNet Buying
AGEN6.07%93.93%Net BuyingNet Buying
CTNM58.45%10.44%Net Buying
ALEC60.42%39.58%Net SellingNet Selling
NKTX63.53%36.47%Net SellingNet Selling
View Top Biotech Stocks

Black Diamond Therapeutics Stock Ownership FAQ

Who owns Black Diamond Therapeutics?

Black Diamond Therapeutics (NASDAQ: BDTX) is owned by 71.67% institutional shareholders, 35.46% Black Diamond Therapeutics insiders, and 0.00% retail investors. Ali Behbahani is the largest individual Black Diamond Therapeutics shareholder, owning 8.97M shares representing 15.78% of the company. Ali Behbahani's Black Diamond Therapeutics shares are currently valued at $23.87M.

If you're new to stock investing, here's how to buy Black Diamond Therapeutics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.